Neurodevelopmental outcomes of children with congenital heart disease: A review

Heather B Howell1, Michele Zaccario2, Sadaf H Kazmi1

  • 1New York University School of Medicine, Department of Pediatrics, 317 East 34th Street, Suite 902, New York, NY 10016, USA.

Insights

Congenital heart defects (CHDs) impact neurodevelopment due to fetal and childhood factors. Early interventions and specialized follow-up are crucial for affected children.

Area of Science:

  • Pediatric Cardiology
  • Developmental Neuroscience
  • Congenital Anomalies

Background:

  • Congenital heart defects (CHDs) are the most common birth anomalies, affecting ~1% of newborns.
  • Improved survival rates in CHD patients necessitate understanding long-term neurodevelopmental outcomes.
  • CHDs range from simple to complex, with varying impacts on physiological function.

Purpose of the Study:

  • To review the multifactorial influences on neurodevelopment in children with CHDs.
  • To outline current recommendations for neurodevelopmental follow-up in this population.
  • To discuss key neurodevelopmental trends observed in children with CHDs.

Main Methods:

  • This is a review article, synthesizing existing literature on CHD and neurodevelopment.
  • It examines risk factors from fetal development through childhood.
  • The review discusses current follow-up practices and observed trends.

Main Results:

  • Neurodevelopmental risks increase with CHD severity, with initial risks present in utero.
  • Complex CHDs can lead to altered fetal circulation, impacting brain oxygenation.
  • Medical and surgical interventions throughout childhood further compound neurodevelopmental vulnerability.

Conclusions:

  • The neurodevelopmental impact of CHDs is multifactorial, cumulative, and synergistic.
  • Early identification of risks and consistent neurodevelopmental monitoring are essential.
  • Specialized care is critical for optimizing outcomes in children with congenital heart disease.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
633
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
329
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
412
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
264
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
350